{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:48:09Z","timestamp":1783633689573,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T00:00:00Z","timestamp":1576627200000},"content-version":"vor","delay-in-days":5464,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1093\/annonc\/mdi021","type":"journal-article","created":{"date-parts":[[2004,12,14]],"date-time":"2004-12-14T21:13:31Z","timestamp":1103058811000},"page":"70-74","source":"Crossref","is-referenced-by-count":47,"title":["Third generation aromatase inhibitors may prevent endometrial growth and reverse tamoxifen-induced uterine changes in postmenopausal breast cancer patients"],"prefix":"10.1016","volume":"16","author":[{"given":"L.","family":"Morales","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Timmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Neven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.","family":"Konstantinovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Carbonez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Van Huffel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ameye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Weltens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-R.","family":"Christiaens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Vergote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Paridaens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdi021_bb0010","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(89)91741-8","article-title":"Tamoxifen and the uterus and endometrium","volume":"i","author":"Neven","year":"1989","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdi021_bb0015","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/S0140-6736(94)92466-X","article-title":"Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial","volume":"343","author":"Kedar","year":"1994","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdi021_bb0020","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"90","author":"Fisher","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdi021_bb0025","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(05)78216-7","article-title":"Should tamoxifen users be screened for endometrial lesions?","volume":"351","author":"Neven","year":"1998","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdi021_bb0030","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00042192-200209000-00012","article-title":"Controversy about uterine effects and safety of SERMs: the saga continues","volume":"9","author":"Goldstein","year":"2002","journal-title":"Menopause"},{"key":"10.1093\/annonc\/mdi021_bb0035","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/bjc.1998.477","article-title":"The effects of norethisterone on endometrial abnormalities identified by transvaginal ultrasound screening of healthy post-menopausal women on tamoxifen or placebo","volume":"78","author":"Powles","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdi021_bb0040","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0140-6736(00)03204-9","article-title":"Endometrial protection from tamoxifen-stimulated changes by a levonorgestrel-releasing intrauterine system: a randomised controlled trial","volume":"356","author":"Gardner","year":"2000","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdi021_bb0045","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1093\/annonc\/mdi021_bb0050","first-page":"419","volume":"362","author":"Lancet","year":"2003","journal-title":"Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study"},{"key":"10.1093\/annonc\/mdi021_bb0055","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1200\/JCO.2001.19.3.881","article-title":"Aromatase inhibitors in the treatment and prevention of breast cancer","volume":"19","author":"Goss","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdi021_bb0060","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/107327480200900606","article-title":"Aromatase inhibitors in breast cancer: An update","volume":"9","author":"Lake","year":"2002","journal-title":"Cancer Control"},{"key":"10.1093\/annonc\/mdi021_bb0065","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/00001813-199809000-00002","article-title":"Safety, activity and estrogen inhibition by exemestane in postmenopausal women with advanced breast cancer: a phase I study","volume":"9","author":"Paridaens","year":"1998","journal-title":"Anti-Cancer Drugs"},{"key":"10.1093\/annonc\/mdi021_bb0070","first-page":"1511","article-title":"In vivo measurement of aromatase inhibition by letrozole (CGS 20267) in postmenopausal patients with breast cancer","volume":"1","author":"Dowsett","year":"1995","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdi021_bb0075","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/bjc.1996.531","article-title":"Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer","volume":"74","author":"Geisler","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdi021_bb0080","first-page":"2131","volume":"359","author":"Lancet","year":"2002"},{"issue":"Suppl 5","key":"10.1093\/annonc\/mdi021_bb0085","first-page":"39","article-title":"Fewer endometrial abnormalities with anastrozole than tamoxifen Endometrial subprotocol results from the ATAC (Arimidex Tamoxifen Alone or in Combination) early breast cancer trial in postmenopausal patients","volume":"13","author":"Duffy","year":"2002","journal-title":"Ann Oncol"},{"issue":"Suppl 4","key":"10.1093\/annonc\/mdi021_bb0090","first-page":"iv7","article-title":"Reversal of tamoxifen induced endometrial modifications by switching to letrozole in early breast cancer patients A prospective TVUS study","volume":"14","author":"Garrone","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdi021_bb0095","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1200\/JCO.2000.18.11.2234","article-title":"Activity of exemestane in metastatic breast cancer after failure of non-steroidal aromatase inhibitors: a phase II trial","volume":"18","author":"Lonning","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdi021_bb0100","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1177\/107327480200902S01","article-title":"Anti-aromatase agents in the treatment and prevention of breast cancer","volume":"9","author":"Goss","year":"2002","journal-title":"Cancer Control"},{"key":"10.1093\/annonc\/mdi021_bb0105","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF00713400","article-title":"Plasma changes in breast cancer patients during endocrine therapy\u2014lipid measurements and nuclear magnetic resonance (NMR) spectroscopy","volume":"36","author":"Engan","year":"1995","journal-title":"Breast Cancer Res Treat"},{"key":"10.1093\/annonc\/mdi021_bb0110","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/annonc\/mdh064","volume":"15","author":"Atalay","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdi021_bb0115","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0959-8049(01)00155-1","article-title":"Effect of letrozole on the lipid profile in postmenopausal women with breast cancer","volume":"37","author":"Elisaf","year":"2001","journal-title":"Eur J Cancer"},{"issue":"Suppl 51","key":"10.1093\/annonc\/mdi021_bb0120","first-page":"51","article-title":"The effect of anastrozole (Arimidex) on serum lipids\u2014data from a randomized comparison of anastrozole versus tamoxifen in postmenopausal women with advanced breast cancer","volume":"64","author":"Dewar","year":"2000","journal-title":"Breast Cancer Res Treat"},{"issue":"Suppl 76","key":"10.1093\/annonc\/mdi021_bb0125","first-page":"576","article-title":"A randomized placebo-controlled explorative study to investigate the effect of low estrogen plasma levels on markers of bone turnover in healthy postmenopausal women during the 12-week treatment with exemestane or letrozole","volume":"76","author":"Goss","year":"2002","journal-title":"Breast Cancer Res Treat"},{"key":"10.1093\/annonc\/mdi021_bb0130","article-title":"Transvaginal ultrasound findings in patients participating in the Intergroup Exemestane Study","author":"Gibson","year":"2005","journal-title":"Proc Am Soc Clin Oncol2002; 21: 486 (Abstr"},{"key":"10.1093\/annonc\/mdi021_bb0135","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0002-9378(98)70294-7","article-title":"A randomized trial on the use of ultrasonography or office hysteroscopy for endometrial assessment in postmenopausal patients with breast cancer who were treated with tamoxifen","volume":"179","author":"Timmerman","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1093\/annonc\/mdi021_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJMoa032312","article-title":"A randomized trial of letrozole in postmenopausal women after 5 years of tamoxifen therapy for early-stage breast cancer","volume":"349","author":"Goss","year":"2003","journal-title":"N Engl J Med"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341941644X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341941644X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/16\/1\/70\/435523\/mdi021.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T13:29:32Z","timestamp":1582205372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092375341941644X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S092375341941644X"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdi021","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}